JNJ-61803534 is an Orally Active RORγt Inverse Agonist with Anti-inflammatory Activity
JNJ-61803534 is a potent and orally active RORγt inverse agonist. JNJ-61803534 exhibits anti-inflammatory activity. It inhibits IL-17A production in human CD4+ T cells under Th17 differentiation conditions. JNJ-61803534 (1 nM-1…